Navigation Links
Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
Date:9/20/2007

Agreement demonstrates broad potential use of Intellect's clinical

candidate

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on the development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and related disorders, and CHDI, Inc., a non-profit organization pursuing the discovery and development of drugs to prevent or slow the progression of Huntington disease (HD), announced today that they have entered into an agreement under which CHDI will assess Intellect's OXIGON(TM) as a potential therapy for Huntington disease. CHDI has access to a variety of relevant research tools, including in vitro and in vivo assays and animal models. Intellect has completed Phase I clinical trials for OXIGON(TM) in elderly healthy volunteers.

Dr. Daniel Chain, CEO and Chairman of Intellect, commented: "We are pleased that CHDI is evaluating whether OXIGON's method of action might extend to Huntington disease. OXIGON(TM) is planned to enter Phase II clinical trials in Alzheimer's patients in 2008. The data generated in the CHDI study could support proceeding with clinical trials in HD patients as well."

"We are intrigued by the properties of this compound, which has demonstrated neuroprotective effects in various animal models," said Robert Pacifici, CHDI's Chief Scientific Officer. "We are pleased to work with the Intellect team to evaluate the usefulness of OXIGON(TM) to treat HD."

About OXIGON(TM)

Intellect's lead drug candidate, OXIGON(TM), is a chemically synthesized form of a naturally occurring molecule that has unique neuroprotectant and antioxidant properties. OXIGON(TM) has been demonstrated to protect the brain from many potent neurotoxins in animals and also to block the formation of toxic aggregates that result from abnormal folding of proteins such as beta amyloid
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Annual Meeting of the Consortium of Multiple Sclerosis Centers Focuses on the Challenges of Care and Research in Multiple Sclerosis
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
5. GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (Entereg/Entrareg)
6. M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data at the AACR Annual Meeting
7. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
8. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
9. Neurogen Proprietary Insomnia Compound Data Presented at Associated Professional Sleep Societies Annual Meeting
10. Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
11. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Calif. , Oct. 31, 2014 ThynkWare ... sclerosis (ALS) patients initiate text and email messages using ... a patent-pending technology invented by ThynkWare,s founder, Duane ... on a smartphone device. This technology allows users to ... only the power of thought. ThynkWare provides ...
(Date:10/31/2014)... Migranade, Inc. announced today the new migraine ... 36 million U.S. migraine sufferers November, 2014. The medicine ... actual cause of migraines and not just the symptoms. ... source Migranade is assured to be a game changer ... available at http://www.migranade.com and will soon hit ...
(Date:10/31/2014)... NORTH CHICAGO, Ill., Oct. 31, 2014  AbbVie ... results for the third quarter ended Sept. 30, ... the strong performance of our business with double-digit ... Our underlying business grew nearly 14 percent in ... chairman and chief executive officer, AbbVie.  "We exceeded ...
Breaking Medicine Technology:ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2Game Changing Migraine Medication To Be Available November 2014 2AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
... Texas, Oct. 4, 2011 Today, Children,s ... in the state and the only stand-alone facility between Dallas ... Earlier, hospital personnel used Scott & White,s state-of-the-art Simulation Center ... Hospital, which was housed in Scott & White Hospital-Temple, before ...
... OTCQX: RHHBY) announced plans today to expand its coagulation testing ... clinics with the development of a full line of coagulation ... expected to be introduced in the U.S. and Canada in ... Roche Diagnostics is the global market leader in coagulation ...
Cached Medicine Technology:Children's Hospital at Scott & White Opens 2Children's Hospital at Scott & White Opens 3Children's Hospital at Scott & White Opens 4Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014 2
(Date:10/31/2014)... The process of cell division is central to life. ... each other, has fascinated scientists since the dawn of ... long, it has been notoriously difficult to study this ... before cleaving in two. , The name given to ... "cell movement" and captures the sense of a highly ...
(Date:10/31/2014)... The Prevention Research Center for Healthy Neighborhoods (PRCHN) ... is a key player in nearly $13.32 million ... in Northeast Ohio. , The Centers for Disease ... for $4.35 million over five years. The funds ... testing, and disseminating individual, environmental, and policy interventions ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Daily Gossip writes ... is actually described as the fastest fat loss program ever ... less than a month. , There is no wonder after ... eBook of all time. The new nutrition and workout fat ... and fitness expert. , According to the author of ...
(Date:10/31/2014)... October 31, 2014 At the start ... families narrowly escaping carbon monoxide poisoning in their homes. ... weeks away, one family-owned, Missouri-based heating and cooling company ... making sure families start the home heating season with ... secure. , Beginning Nov. 1, 2014, E and ...
(Date:10/31/2014)... Tampa, FL (PRWEB) October 31, 2014 ... Infrared-Active compression gear. The new gear is now available ... information on the benefits of Celliant infrared-active athletic gear ... recently reported that another contract has been signed for ... Olympic speedskaters for the next eight years. In light ...
Breaking Medicine News(10 mins):Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4
... treatment, radiation may be a better choice than ... cancer, //according to a randomized controlled trial published ... The authors suggest that a combination of chemotherapy ... for these patients. ,Approximately 80 percent of ...
... finds that survivors of acute lymphoblastic leukemia have a ... the general population. // ,Acute lymphoblastic leukemia is ... almost 4,000 new cases diagnosed in the United States ... curable pediatric cancers: survival rates for patients who receive ...
... a weekly treatment with a nasal spray of virus enzymes ... based on results of a study. Such a treatment would ... avoiding the problem of antibiotic resistance. ,Middle ear ... the middle ear space that can cause pain, fever, irritability, ...
... the state government on a public suit demanding// protection ... litigation (PIL), filed by an NGO, Health, Environment and ... to be protected from silicosis, which is rife due ... malpractice of the mine owners. ,"We had ...
... Pitt donated $100,000 of their money to help// construct the ... ,They made the donation to the Duk Lost Boys Clinic ... in the spring and serve more than 150,000 people. ... of the "lost boys" of Sudan who is the director ...
... urged governments to join the anti-tuberculosis global plan, which ... the disease has become extremely drug-resistant. ,Ban's ... Day on Saturday. The World Health Organization (WHO) recently ... strain of tuberculosis, XDR-TB, which threatens to derail efforts ...
Cached Medicine News:Health News:Radiation Preferred Over Surgery for Patients With Some Stages of Lung Cancer 2Health News:Lymphoblastic Leukemia Survivors at Risk for Secondary Cancer 2Health News:Viral Enzyme Recruited in Fight Against Ear Infection 2Health News:Viral Enzyme Recruited in Fight Against Ear Infection 3Health News:Public Interest Litigation Filed Favoring Mineworkers Against Silicosis 2
... protection to the exposed airway of the tracheostomy ... it ideal for active young children as well ... and moisture recovery, it ensures patient comfort and ... have ISO standard tapered ends to assure a ...
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
Medicine Products: